Tag Archive: Novartis

Feb 12 2013

Everything You Need to Know About Priority Review Vouchers: Part 1 of 2

The Basics, History, and Record of the Priority Review Voucher Program The Basics If your company’s goals include funding pipeline development or increasing speed to market you should, at least, be familiar with the concept of the Priority Review Voucher (PRV). A PRV would be aptly described as an obscure or esoteric regulatory curiosity by …

Continue reading »

May 17 2010

DDMAC Sends Warning Letter Over Unbranded Websites

If you judge, investigate. – Seneca I know you just read the title, but let me say it again with some emphasis:  DDMAC Sends Warning Letter Over Unbranded Websites.  That’s right, a warning letter over websites that contained no “direct” references to a product…although, as we’ll see, the indirect references were too direct for the …

Continue reading »

Apr 21 2010

Blockbuster Sales Forecasts for 2010 and 2014

The most reliable way to forecast the future is to try to understand the present. – John Naisbitt Interested in what blockbuster drug sales may be like for the next 4 years?  Trying to position your developing therapeutic against the current and future marketplace?  Reuters just released a FACTBOX that contained a forecast of the …

Continue reading »